Senior Director
THERMOFISHER SCIENTIFIC
Seth Sadis is the Senior Director of Bioinformatics in the Clinical Sequencing Division of Thermo Fisher Scientific. Seth's team led the development of the original Oncomine™ Assays that are now used globally for targeted profiling of cancer. Seth earned a PhD in Biochemistry from the University of Connecticut and completed a postdoctoral fellowship at Harvard Medical School. Prior to joining Thermo Fisher Scientific, Seth led teams in oncology drug discovery with Millennium Pharmaceuticals and in translational medicine and clinical development at Pfizer. Seth’s team continues to support the development of Oncomine™ Assays with a focus on integrated variant annotation and interpretation solutions.